cd20+ nhl
Item
b-cell, cd20+ nhl
boolean
C0024305 (UMLS CUI [1,1])
C0054946 (UMLS CUI [1,2])
engraftment of autologous peripheral blood stem cell transplant
Item
evidence of engraftment post-autologous peripheral blood stem cell transplant (pbsc-t), aka autologous stem cell transplant (asct)
boolean
C1960579 (UMLS CUI [1])
C0301944 (UMLS CUI [2])
ecog
Item
eastern cooperative oncology group (ecog) performance status 0 to 1
boolean
C1520224 (UMLS CUI [1])
creatinine
Item
creatinine < 2 mg/dl
boolean
C0201976 (UMLS CUI [1])
bilirubin
Item
bilirubin < 2.0 mg/dl
boolean
C1278039 (UMLS CUI [1])
liver function
Item
liver function tests (lfts) < 5 x upper limit of normal (uln)
boolean
C0232741 (UMLS CUI [1])
bone marrow transplant
Item
graft source from bone marrow
boolean
C0005961 (UMLS CUI [1])
non-responders to anti cd20 therapy
Item
non-responders [progressive disease (pd) or stable disease (sd)] to prior anti-cd20 therapy
boolean
C0919875 (UMLS CUI [1])
C3891557 (UMLS CUI [2])
pd after asct
Item
progressive disease after asct
boolean
C1335499 (UMLS CUI [1])
C2193200 (UMLS CUI [2])
radiotherapy
Item
post-asct radiotherapy
boolean
C1522449 (UMLS CUI [1])
concomitant therapy
Item
concomitant treatment with radiotherapy, chemotherapy or immunotherapy including rituximab
boolean
C1707479 (UMLS CUI [1])
pneumonitis
Item
evidence of active pneumonitis
boolean
C3714636 (UMLS CUI [1])
active infection
Item
evidence of active infection
boolean
C0009450 (UMLS CUI [1])
systemic steroids
Item
concurrent prednisone or other systemic steroid medication
boolean
C2825233 (UMLS CUI [1])
nitrosourea after rituximab
Item
nitrosourea therapy within 6 weeks of the first treatment with rituximab
boolean
C0028210 (UMLS CUI [1])
C0393022 (UMLS CUI [2])
Human anti-mouse antibody
Item
presence of anti-murine antibody (hama) reactivity
boolean
C1291910 (UMLS CUI [1])